Aigen Investment Management LP purchased a new position in shares of Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 18,093 shares of the basic materials company’s stock, valued at approximately $930,000.
Other large investors have also recently bought and sold shares of the company. Glenmede Trust Co. NA grew its stake in shares of Cameco by 2.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 9,149 shares of the basic materials company’s stock valued at $437,000 after buying an additional 191 shares during the period. Heritage Wealth Management Inc. grew its stake in shares of Cameco by 0.8% in the 4th quarter. Heritage Wealth Management Inc. now owns 30,875 shares of the basic materials company’s stock valued at $1,587,000 after buying an additional 250 shares during the period. MassMutual Private Wealth & Trust FSB grew its stake in shares of Cameco by 48.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 816 shares of the basic materials company’s stock valued at $42,000 after buying an additional 267 shares during the period. EdgeRock Capital LLC grew its stake in shares of Cameco by 2.2% in the 4th quarter. EdgeRock Capital LLC now owns 13,986 shares of the basic materials company’s stock valued at $719,000 after buying an additional 297 shares during the period. Finally, Highview Capital Management LLC DE grew its stake in shares of Cameco by 5.0% in the 4th quarter. Highview Capital Management LLC DE now owns 6,246 shares of the basic materials company’s stock valued at $321,000 after buying an additional 300 shares during the period. 70.21% of the stock is currently owned by institutional investors and hedge funds.
Cameco Price Performance
Shares of NYSE CCJ opened at $42.99 on Thursday. Cameco Co. has a fifty-two week low of $35.43 and a fifty-two week high of $62.55. The stock has a market cap of $18.71 billion, a price-to-earnings ratio of 153.52 and a beta of 0.94. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88. The firm’s 50-day simple moving average is $49.22 and its 200 day simple moving average is $49.95.
Wall Street Analyst Weigh In
CCJ has been the subject of several research reports. Royal Bank of Canada restated an “outperform” rating and issued a $90.00 target price on shares of Cameco in a research note on Tuesday. StockNews.com upgraded Cameco from a “sell” rating to a “hold” rating in a research note on Friday, February 21st. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $71.25.
Check Out Our Latest Analysis on Cameco
About Cameco
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Articles
- Five stocks we like better than Cameco
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What is a buyback in stocks? A comprehensive guide for investors
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What Are Trending Stocks? Trending Stocks Explained
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.